Celadon Pharmaceuticals PLC
CEL
Company Profile
Business description
Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis. It operates only in the UK and has only one geographical area.
Contact
32-33 Cowcross Street
LondonEC1M 6DF
GBRT: +44 2031500252
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
19
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,796.00 | 23.70 | -0.27% |
| CAC 40 | 7,775.68 | 0.22 | -0.00% |
| DAX 40 | 23,850.50 | 98.40 | -0.41% |
| Dow JONES (US) | 42,834.51 | 31.26 | -0.07% |
| FTSE 100 | 8,883.76 | 19.41 | 0.22% |
| HKSE | 24,035.38 | 331.56 | -1.36% |
| NASDAQ | 19,637.63 | 21.75 | 0.11% |
| Nikkei 225 | 38,173.09 | 248.10 | -0.65% |
| NZX 50 Index | 12,649.10 | 43.17 | 0.34% |
| S&P 500 | 6,031.74 | 9.50 | 0.16% |
| S&P/ASX 200 | 8,565.10 | 27.00 | -0.31% |
| SSE Composite Index | 3,402.66 | 0.34 | 0.01% |